{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:21:07Z","timestamp":1783689667946,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jfma.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T02:01:11Z","timestamp":1679882471000},"page":"1042-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9661-9817","authenticated-orcid":false,"given":"Yen-Ling","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-3395","authenticated-orcid":false,"given":"Chung-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-5840","authenticated-orcid":false,"given":"Shu-Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Chyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Heng","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ming","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Wang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Tang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-1658","authenticated-orcid":false,"given":"Jia-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-4958","authenticated-orcid":false,"given":"Chen-Shuan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.03.017_bib1","series-title":"The center for systems science and engineering (CSSE) at johns Hopkins University (JHU). COVID-19 dashboard","year":"2022"},{"key":"10.1016\/j.jfma.2023.03.017_bib2","first-page":"54","article-title":"Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study","volume":"17","author":"Yen","year":"2019","journal-title":"Int Res"},{"key":"10.1016\/j.jfma.2023.03.017_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOG.0000000000000741","article-title":"Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic","volume":"37","author":"El Ouali","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jfma.2023.03.017_bib4","first-page":"159","volume":"vol. 9","author":"Singh","year":"2021"},{"key":"10.1016\/j.jfma.2023.03.017_bib5","doi-asserted-by":"crossref","first-page":"649759","DOI":"10.3389\/fmed.2021.649759","article-title":"Impact of the lockdown due to the COVID-19 pandemic on patients with inflammatory bowel disease","volume":"8","author":"Nishida","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jfma.2023.03.017_bib6","first-page":"226","article-title":"Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2","volume":"131","author":"\u0141odyga","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jfma.2023.03.017_bib7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.14309\/ajg.0000000000000830","article-title":"Epidemiology and the impact of therapies on the outcome of COVID-19 in patients with inflammatory bowel disease","volume":"115","author":"Papa","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2023.03.017_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/flgastro-2020-101531","article-title":"Implications of recurrent SARS-CoV-2 outbreaks for IBD management","volume":"12","author":"Segal","year":"2021","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.jfma.2023.03.017_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jgh3.12537","article-title":"Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic","volume":"5","author":"Barnes","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.jfma.2023.03.017_bib10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1053\/j.gastro.2021.06.012","article-title":"Risk of venous thromboembolism among patients with inflammatory bowel disease who contract severe acute respiratory syndrome coronavirus 2","volume":"161","author":"Mahmud","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2023.03.017_bib11","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/ibd\/izab150","article-title":"SARS-CoV-2 vaccination in patients with inflammatory bowel disease-fear and desire","volume":"27","author":"Walldorf","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jfma.2023.03.017_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5009\/gnl210064","article-title":"Perceptions and behaviors of patients with inflammatory bowel disease during the COVID-19 crisis","volume":"16","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.jfma.2023.03.017_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.dld.2020.12.120","article-title":"Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs","volume":"53","author":"Bossa","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jfma.2023.03.017_bib14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3748\/wjg.v27.i11.1022","article-title":"How to manage inflammatory bowel disease during the COVID-19 pandemic: a guide for the practicing clinician","volume":"27","author":"Chebli","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2023.03.017_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jgh.15164","article-title":"Zero COVID-19 infection in inflammatory bowel disease patients: findings from population-based inflammatory bowel disease registries in Hong Kong and Taiwan","volume":"36","author":"Mak","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.03.017_bib16","article-title":"Monthly number of cases within the past 5 Years, severe pneumonia with novel pathogens (COVID-19), indigenous and imported","volume":"2022","year":"2022","journal-title":"Nationwide"},{"key":"10.1016\/j.jfma.2023.03.017_bib17","first-page":"2418","article-title":"Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease","volume":"25","author":"Scucchi","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jfma.2023.03.017_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2021.09.011","article-title":"Impact of medications on COVID-19 outcomes in inflammatory bowel disease: analysis of more than 6000 patients from an international registry","volume":"162","author":"Ungaro","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2023.03.017_bib19","first-page":"3529","article-title":"Biologics in systemic autoimmune diseases during","volume":"39","author":"Annapureddy","year":"2020","journal-title":"COVID-19 pandemic"},{"key":"10.1016\/j.jfma.2023.03.017_bib20","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1093\/ibd\/izaa242","article-title":"Biologic therapies may reduce the risk of COVID-19 in patients with inflammatory bowel disease","volume":"26","author":"Bezzio","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jfma.2023.03.017_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MEG.0000000000002239","article-title":"Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience","volume":"34","author":"Richter","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.03.017_bib22","first-page":"3","article-title":"Management of inflammatory bowel disease in the COVID-19 era","volume":"20","author":"Kim","year":"2022","journal-title":"Int Res"},{"key":"10.1016\/j.jfma.2023.03.017_bib23","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2020.06.044","article-title":"Adherence of infusible biologics during the time of COVID-19 among patients with inflammatory bowel disease: a nationwide veterans affairs cohort study","volume":"159","author":"Khan","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2023.03.017_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gastrohep.2021.03.012","article-title":"Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease","volume":"45","author":"Refaie","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.03.017_bib25","doi-asserted-by":"crossref","first-page":"S780","DOI":"10.1093\/ecco-jcc\/jjaa140","article-title":"International organization for the study of inflammatory bowel disease: global strategies for telemedicine and inflammatory bowel diseases","volume":"14","author":"Lewin","year":"2020","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10.1016\/j.jfma.2023.03.017_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10620-021-06874-x","article-title":"Successful distancing: telemedicine in gastroenterology and Hepatology during the COVID-19 pandemic","volume":"66","author":"Perisetti","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jfma.2023.03.017_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.dld.2020.10.035","article-title":"Trust in telemedicine from IBD outpatients during the COVID-19 pandemic","volume":"53","author":"Costantino","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jfma.2023.03.017_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M20-1447","article-title":"Clinician education and adoption of preventive measures for COVID-19: a survey of a convenience sample of general practitioners in Lombardy","volume":"173","author":"Fiorino","year":"2020","journal-title":"Italy, Ann Intern Med"},{"key":"10.1016\/j.jfma.2023.03.017_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2023.03.017_bib30","series-title":"Adverse events following SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease","author":"Botwin","year":"2021"},{"key":"10.1016\/j.jfma.2023.03.017_bib31","article-title":"Our world in data","year":"2022","journal-title":"Coronavirus Pandemic"},{"key":"10.1016\/j.jfma.2023.03.017_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ueg2.12103","article-title":"What gastroenterologists should know about SARS-CoV 2 vaccine: world Endoscopy Organization perspective","volume":"9","author":"Spadaccini","year":"2021","journal-title":"United European Gastroenterol"},{"key":"10.1016\/j.jfma.2023.03.017_bib33","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1053\/j.gastro.2021.06.014","article-title":"COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: analysis of a Large multi-institutional research network in the United States","volume":"161","author":"Hadi","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462300102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462300102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:49:41Z","timestamp":1760539781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462300102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S092966462300102X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.03.017","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}